In vitro induction of carcinoembryonic antigen (CEA) specific cytotoxic T lymphocytes using dendritic cells pulsed with CEA peptide
MH PARK, CS LEE, MH CHO, C Han… - Journal of the …, 2005 - pesquisa.bvsalud.org
PURPOSE: Dendritic cells (DCs) are the most potent antigen-presenting cells for initiating
the T cell immune response in vivo. Recent studies have shown that active immunotherapy …
the T cell immune response in vivo. Recent studies have shown that active immunotherapy …
In Vitro Induction of Carcinoembryonic Antigen (CEA) Specific Cytotoxic T Lymphocytes Using Dendritic Cells Pulsed with CEA Peptide
MH Park, CS Lee, MH Cho, C Han, YS Koh, JC Kim… - Journal of the Korean … - KoreaMed
PURPOSE Dendritic cells (DCs) are the most potent antigen-presenting cells for initiating
the T cell immune response in vivo. Recent studies have shown that active immunotherapy …
the T cell immune response in vivo. Recent studies have shown that active immunotherapy …
In Vitro Induction of Carcinoembryonic Antigen (CEA) Specific Cytotoxic T Lymphocytes Using Dendritic Cells Pulsed with CEA Peptide.
MH Park, CS Lee, MH Cho, C Han… - Journal of the …, 2005 - wprim.whocc.org.cn
PURPOSE: Dendritic cells (DCs) are the most potent antigen-presenting cells for initiating
the T cell immune response in vivo. Recent studies have shown that active immunotherapy …
the T cell immune response in vivo. Recent studies have shown that active immunotherapy …
In Vitro Induction of Carcinoembryonic Antigen (CEA) Specific Cytotoxic T Lymphocytes Using Dendritic Cells Pulsed with CEA Peptide
MH Park, CS Lee, MH Cho, C Han, YS Koh, JC Kim… - Journal of the Korean … - KoreaMed
PURPOSE Dendritic cells (DCs) are the most potent antigen-presenting cells for initiating
the T cell immune response in vivo. Recent studies have shown that active immunotherapy …
the T cell immune response in vivo. Recent studies have shown that active immunotherapy …